Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 433

1.

Cannabinoids and Symptomatic Bradycardia.

Heckle MR, Nayyar M, Sinclair SE, Weber KT.

Am J Med Sci. 2018 Jan;355(1):3-5. doi: 10.1016/j.amjms.2017.03.027. Epub 2017 Mar 22. Review.

PMID:
29289259
2.

Secondary Hyperparathyroidism in Heart Failure.

Morsy MS, Dishmon DA, Garg N, Weber KT.

Am J Med Sci. 2017 Oct;354(4):335-338. doi: 10.1016/j.amjms.2017.02.008. Epub 2017 Mar 2. Review.

PMID:
29078836
3.

K+ and Mg2+ Dyshomeostasis in Acute Hyperadrenergic Stressor States.

Nayyar M, Yusuf J, Khan MU, Weber KT.

Am J Med Sci. 2017 May;353(5):422-424. doi: 10.1016/j.amjms.2017.01.001. Epub 2017 Jan 7. Review.

PMID:
28502326
4.

Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease.

Weber KT, Sun Y, Gerling IC, Guntaka RV.

Am J Hypertens. 2017 Nov 1;30(11):1049-1052. doi: 10.1093/ajh/hpx054.

PMID:
28379281
5.

Depressed Myocardial Contractility: Can It Be Rescued?

Weber KT.

Am J Med Sci. 2016 Oct;352(4):428-432. doi: 10.1016/j.amjms.2016.05.026. Epub 2016 May 30. Review.

PMID:
27776727
6.

Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure.

Weber KT, Díez J.

Circ Heart Fail. 2016 Aug;9(8). pii: e003315. doi: 10.1161/CIRCHEARTFAILURE.116.003315. No abstract available.

7.

Mineralocorticoid Receptor Antagonists in the Management of Heart Failure and Resistant Hypertension: A Review.

Flatt DM, Brown MC, Mizeracki AM, King BJ, Weber KT.

JAMA Cardiol. 2016 Aug 1;1(5):607-12. doi: 10.1001/jamacardio.2016.1878.

PMID:
27434136
8.

Cunning metal core: efficiency/stability dilemma in metallated porphyrin based light-emitting electrochemical cells.

Weber KT, Karikis K, Weber MD, Coto PB, Charisiadis A, Charitaki D, Charalambidis G, Angaridis P, Coutsolelos AG, Costa RD.

Dalton Trans. 2016 Sep 14;45(34):13284-8. doi: 10.1039/c6dt02293f. Epub 2016 Jul 1.

PMID:
27363542
9.

Predictors of quality of life after moderate to severe traumatic brain injury.

Weber KT, Guimarães VA, Pontes Neto OM, Leite JP, Takayanagui OM, Santos-Pontelli TE.

Arq Neuropsiquiatr. 2016 May;74(5):409-15. doi: 10.1590/0004-282X20160053.

10.

Atrophied cardiomyocytes and their potential for rescue and recovery of ventricular function.

Heckle MR, Flatt DM, Sun Y, Mancarella S, Marion TN, Gerling IC, Weber KT.

Heart Fail Rev. 2016 Mar;21(2):191-8. doi: 10.1007/s10741-016-9535-x. Review.

PMID:
26872676
11.

Myofibroblast secretome and its auto-/paracrine signaling.

Bomb R, Heckle MR, Sun Y, Mancarella S, Guntaka RV, Gerling IC, Weber KT.

Expert Rev Cardiovasc Ther. 2016;14(5):591-8. doi: 10.1586/14779072.2016.1147348. Epub 2016 Feb 17. Review.

12.

Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases.

Weber KT, Alipui DO, Sison CP, Bloom O, Quraishi S, Overby MC, Levine M, Chahine NO.

Arthritis Res Ther. 2016 Jan 7;18:3. doi: 10.1186/s13075-015-0887-8.

13.

Exploratory study for identifying systemic biomarkers that correlate with pain response in patients with intervertebral disc disorders.

Weber KT, Satoh S, Alipui DO, Virojanapa J, Levine M, Sison C, Quraishi S, Bloom O, Chahine NO.

Immunol Res. 2015 Dec;63(1-3):170-80. doi: 10.1007/s12026-015-8709-2.

14.

VEGF-C/VEGFR-3 pathway promotes myocyte hypertrophy and survival in the infarcted myocardium.

Zhao T, Zhao W, Meng W, Liu C, Chen Y, Gerling IC, Weber KT, Bhattacharya SK, Kumar R, Sun Y.

Am J Transl Res. 2015 Apr 15;7(4):697-709. eCollection 2015.

15.

Spatial and Census Data to Evaluate Obese Persons and their Environment (SCOPE).

Nies MA, Weber KT, Holmes J, Peterson T, Serr K, Arias J, Lim WY, Force R.

Am J Health Behav. 2015 Jul;39(4):582-8. doi: 10.5993/AJHB.39.4.15.

PMID:
26018107
16.

Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Weber KT, Jacobsen TD, Maidhof R, Virojanapa J, Overby C, Bloom O, Quraishi S, Levine M, Chahine NO.

Curr Rev Musculoskelet Med. 2015 Mar;8(1):18-31. doi: 10.1007/s12178-014-9253-8.

17.

Zinc and the prooxidant heart failure phenotype.

Efeovbokhan N, Bhattacharya SK, Ahokas RA, Sun Y, Guntaka RV, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2014 Oct;64(4):393-400. doi: 10.1097/FJC.0000000000000125. Review.

18.

Proteome analysis of subsarcolemmal cardiomyocyte mitochondria: a comparison of different analytical platforms.

Giorgianni F, Koirala D, Weber KT, Beranova-Giorgianni S.

Int J Mol Sci. 2014 May 26;15(6):9285-301. doi: 10.3390/ijms15069285.

19.

Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery.

Al Darazi F, Zhao W, Zhao T, Sun Y, Marion TN, Ahokas RA, Bhattacharya SK, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2014 Sep;64(3):237-46. doi: 10.1097/FJC.0000000000000111.

20.

Gene expression profiles of peripheral blood mononuclear cells reveal transcriptional signatures as novel biomarkers of cardiac remodeling in rats with aldosteronism and hypertensive heart disease.

Gerling IC, Ahokas RA, Kamalov G, Zhao W, Bhattacharya SK, Sun Y, Weber KT.

JACC Heart Fail. 2013 Dec;1(6):469-76. doi: 10.1016/S2213-1779(13)00374-0. Epub 2013 Dec 2.

21.

Gene Expression Profiles of Peripheral Blood Mononuclear Cells Reveal Transcriptional Signatures as Novel Biomarkers for Cardiac Remodeling in Rats with Aldosteronism and Hypertensive Heart Disease.

Gerling IC, Ahokas RA, Kamalov G, Zhao W, Bhattacharya SK, Sun Y, Weber KT.

JACC Heart Fail. 2013 Dec 1;1(6). doi: 10.1016/j.jchf.2013.09.003.

22.

Phosphoproteome mapping of cardiomyocyte mitochondria in a rat model of heart failure.

Giorgianni F, Usman Khan M, Weber KT, Gerling IC, Beranova-Giorgianni S.

Mol Cell Biochem. 2014 Apr;389(1-2):159-67. doi: 10.1007/s11010-013-1937-7. Epub 2014 Jan 7.

23.

Atrophic cardiomyocyte signaling in hypertensive heart disease.

Kamalov G, Zhao W, Zhao T, Sun Y, Ahokas RA, Marion TN, Al Darazi F, Gerling IC, Bhattacharya SK, Weber KT.

J Cardiovasc Pharmacol. 2013 Dec;62(6):497-506. doi: 10.1097/FJC.0000000000000011.

24.

Nebivolol: a multifaceted antioxidant and cardioprotectant in hypertensive heart disease.

Khan MU, Zhao W, Zhao T, Al Darazi F, Ahokas RA, Sun Y, Bhattacharya SK, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2013 Nov;62(5):445-51. doi: 10.1097/FJC.0b013e3182a0b5ff.

PMID:
23921314
25.

Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC.

Nat Rev Cardiol. 2013 Jan;10(1):15-26. doi: 10.1038/nrcardio.2012.158. Epub 2012 Dec 4. Review.

PMID:
23207731
26.

Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism.

Khan MU, Khalid H, Salpietro V, Weber KT.

Am J Med Sci. 2013 Sep;346(3):194-8. doi: 10.1097/MAJ.0b013e31826e3635.

PMID:
23187300
27.

Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.

Seawell MR, Al Darazi F, Farah V, Ramanathan KB, Newman KP, Bhattacharya SK, Weber KT.

Curr Heart Fail Rep. 2013 Mar;10(1):36-45. doi: 10.1007/s11897-012-0120-x. Review.

28.

Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Yusuf J, Khan MU, Cheema Y, Bhattacharya SK, Weber KT.

Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):77-86. doi: 10.1016/j.pcad.2012.02.004. Review.

29.

Southern Society for Clinical Investigation Founders' Medal acceptance.

Weber KT.

Am J Med Sci. 2012 Jul;344(1):10-1. doi: 10.1097/MAJ.0b013e3182594cdd. No abstract available.

PMID:
22744366
30.

The Southern Society for Clinical Investigation challenge: anyone, anywhere, anytime.

Weber KT.

Am J Med Sci. 2012 Jul;344(1):1-2. doi: 10.1097/MAJ.0b013e3182538f33. No abstract available.

PMID:
22744360
31.

Cation interdependency in acute stressor states.

Khan MU, Komolafe BO, Weber KT.

Am J Med Sci. 2013 May;345(5):401-4. doi: 10.1097/MAJ.0b013e318253cb07. Review.

PMID:
22739557
32.

Reverse remodeling and recovery from cachexia in rats with aldosteronism.

Cheema Y, Zhao W, Zhao T, Khan MU, Green KD, Ahokas RA, Gerling IC, Bhattacharya SK, Weber KT.

Am J Physiol Heart Circ Physiol. 2012 Aug 15;303(4):H486-95. doi: 10.1152/ajpheart.00192.2012. Epub 2012 Jun 22.

33.

Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism.

Rutledge MR, Farah V, Adeboye AA, Seawell MR, Bhattacharya SK, Weber KT.

Cardiovasc Drugs Ther. 2013 Apr;27(2):161-70. doi: 10.1007/s10557-012-6378-0. Review.

PMID:
22373564
34.

Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states.

Khan MU, Cheema Y, Shahbaz AU, Ahokas RA, Sun Y, Gerling IC, Bhattacharya SK, Weber KT.

Pflugers Arch. 2012 Jul;464(1):123-31. doi: 10.1007/s00424-012-1079-x. Epub 2012 Feb 11. Review.

35.

Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.

Shaheen M, Cheema Y, Shahbaz AU, Bhattacharya SK, Weber KT.

Exp Clin Cardiol. 2011 Winter;16(4):109-15.

36.

Congestive heart failure: pathophysiologic consequences of neurohormonal activation and the potential for recovery: part II.

Dube P, Weber KT.

Am J Med Sci. 2011 Dec;342(6):503-6. doi: 10.1097/MAJ.0b013e3182327527. Review.

PMID:
22108172
37.

Congestive heart failure: pathophysiologic consequences of neurohormonal activation and the potential for recovery: part I.

Dube P, Weber KT.

Am J Med Sci. 2011 Nov;342(5):348-51. doi: 10.1097/MAJ.0b013e318232750d. Review.

PMID:
22030844
38.

Introduction.

Weber KT.

Am J Med Sci. 2011 Nov;342(5):347. doi: 10.1097/MAJ.0b013e3182314ba8. No abstract available.

PMID:
22030843
39.

Spironolactone prevents the inducibility of ventricular tachyarrhythmia in rats with aldosteronism.

Deshmukh PA, Bellary SR, Schwender FT, Kamalov G, Magotra M, de Jongh Curry AL, Sun Y, Weber KT.

J Cardiovasc Pharmacol. 2011 Nov;58(5):487-91. doi: 10.1097/FJC.0b013e31822a78c1.

PMID:
21753736
40.

Oxidative stress and cardiomyocyte necrosis with elevated serum troponins: pathophysiologic mechanisms.

Robinson AD, Ramanathan KB, McGee JE, Newman KP, Weber KT.

Am J Med Sci. 2011 Aug;342(2):129-34. doi: 10.1097/MAJ.0b013e3182231ee3. Review.

PMID:
21747281
41.

Oxidative stress and cardiovascular injury: a symposium presented at the Southern Society for Clinical Investigation.

Weber KT.

Am J Med Sci. 2011 Aug;342(2):111-3. doi: 10.1097/MAJ.0b013e318224a71e. No abstract available.

PMID:
21747277
42.

Stressor states and the cation crossroads.

Weber KT, Bhattacharya SK, Newman KP, Soberman JE, Ramanathan KB, McGee JE, Malik KU, Hickerson WL.

J Am Coll Nutr. 2010 Dec;29(6):563-74. Review.

PMID:
21677120
43.

Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol.

Cheema Y, Sherrod JN, Zhao W, Zhao T, Ahokas RA, Sun Y, Gerling IC, Bhattacharya SK, Weber KT.

J Cardiovasc Pharmacol. 2011 Jul;58(1):80-6. doi: 10.1097/FJC.0b013e31821cd83c.

44.

Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.

Borkowski BJ, Cheema Y, Shahbaz AU, Bhattacharya SK, Weber KT.

Eur Heart J. 2011 Aug;32(15):1846-53. doi: 10.1093/eurheartj/ehr063. Epub 2011 Mar 12.

45.

A treasure trove of talent.

Weber KT.

Am J Med Sci. 2011 Apr;341(4):263-5. doi: 10.1097/MAJ.0b013e3182113424. No abstract available.

PMID:
21372661
46.

Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D.

Zia AA, Komolafe BO, Moten M, Ahokas RA, McGee JE, William Rosenberg E, Bhattacharya SK, Weber KT.

Am J Med Sci. 2011 Feb;341(2):113-8. doi: 10.1097/MAJ.0b013e3182058864.

PMID:
21239963
47.

Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.

Shahbaz AU, Zhao T, Zhao W, Johnson PL, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H636-44. doi: 10.1152/ajpheart.00900.2010. Epub 2010 Nov 12.

48.

Mitochondria-targeted cardioprotection in aldosteronism.

Shahbaz AU, Kamalov G, Zhao W, Zhao T, Johnson PL, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2011 Jan;57(1):37-43. doi: 10.1097/FJC.0b013e3181fe1250.

49.

Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies.

Shahbaz AU, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, McGee JE, Weber KT.

J Hypertens. 2010 Sep;28 Suppl 1:S25-32. doi: 10.1097/01.hjh.0000388491.35836.d2. Review.

50.

From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.

Zia AA, Kamalov G, Newman KP, McGee JE, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT.

Hypertens Res. 2010 Nov;33(11):1091-101. doi: 10.1038/hr.2010.159. Epub 2010 Sep 9. Review.

PMID:
20827279

Supplemental Content

Loading ...
Support Center